| Treatment of female pattern hair loss with a combination of spironolactone and minoxidil. | |
| | |
MedLine Citation:
|
PMID: 17222303 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
A 53-year-old woman with clinical evidence of female pattern hair loss and histological evidence of androgenetic alopecia was initially treated with the oral antiandrogen spironolactone 200 mg daily. Serial scalp photography documented hair regrowth at 12 months; however, the hair regrowth plateaued, and at 24 months there had been no further improvement in hair density. Twice daily therapy with topical minoxidil 5% solution was then introduced and further regrowth documented, confirming the additive effect of combination therapy. |
| | |
Authors:
|
Carlijn Hoedemaker; Sylvia van Egmond; Rodney Sinclair |
Related Documents
:
|
7221893 - Surgical separation of conjoined (siamese) xiphopagus twins. 22444553 - Effects of mineral supplements on ovulation and maturation of dog oocytes. 9104573 - Maternal and neonatal essential fatty acid status in phospholipids: an international co... |
Publication Detail:
|
Type: Case Reports; Journal Article |
Journal Detail:
|
Title: The Australasian journal of dermatology Volume: 48 ISSN: 0004-8380 ISO Abbreviation: Australas. J. Dermatol. Publication Date: 2007 Feb |
Date Detail:
|
Created Date: 2007-01-15 Completed Date: 2007-03-09 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 0135232 Medline TA: Australas J Dermatol Country: Australia |
Other Details:
|
Languages: eng Pagination: 43-5 Citation Subset: IM |
Affiliation:
|
Department of Dermatology, St Vincent's Hospital, University of Melbourne, Melbourne, Victoria, Australia. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Administration, Cutaneous Administration, Oral Aldosterone Antagonists / administration & dosage, therapeutic use* Alopecia / diagnosis*, drug therapy*, pathology Drug Therapy, Combination Female Humans Middle Aged Minoxidil / administration & dosage, therapeutic use* Spironolactone / administration & dosage, therapeutic use* Vasodilator Agents / administration & dosage, therapeutic use* |
| Chemical | |
Reg. No./Substance:
|
0/Aldosterone Antagonists; 0/Vasodilator Agents; 38304-91-5/Minoxidil; 52-01-7/Spironolactone |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Fabry disease in a heterozygote presenting as hand ischaemia and painful acroparaesthesia.
Next Document: A 30-year history of CD4+ vesiculo-bullous mycosis fungoides and multiple visceral malignancies.